Flow Cytometric Analysis of Benign and Malignant Tumors

流式细胞术单元通过为NCI临床方案的患者或正在接受测试以确定所述方案的资格的患者提供白血病和淋巴瘤的诊断测试，为NCI临床方案提供广泛的支持。流式细胞术单元提供NCI和NIH患者血液、骨髓、细针抽吸物、组织活检和体液的临床流式细胞术评价，以确定是否存在血淋巴瘤。由流式细胞术单位进行的大部分流式细胞术检测涉及微小残留病变的检测（患者在按照NCI方案入组之前在外部机构接受治疗后的状态）和各种临床方案规定的特定肿瘤细胞特征的测量。该单位的重大努力致力于提供许多商业实验室不提供的独特方案规定的测定。流式细胞术单位还积极参与教育国家卫生研究院的工作人员和整个医学界在医疗实践中正确使用流式细胞术。

The Flow Cytometry Unit provides extensive support for NCI clinical protocols by providing diagnostic testing for leukemia and lymphoma in patients either on NCI clinical protocols or undergoing testing to determine eligibility for said protocols. The Flow Cytometry Unit provides clinical flow cytometric evaluation of blood, bone marrow, fine needle aspirates, tissue biopsies and body fluids for hematolymphoid neoplasia in NCI and NIH patients. The majority of flow cytometric testing performed by the Flow Cytometry Unit involves detection of minimal residual disease (patients are status post therapy at outside institution prior to enrollment on NCI protocol) and measurement of specific tumor cell characteristics mandated by various clinical protocols. Significant effort in the unit is devoted to delivery of numerous unique protocol mandated assays that are not offered by commercial laboratories. The Flow Cytometry Unit is also actively engaged in education of the NIH staff and medical community at large in the proper utility of flow cytometry in medical practice.